Don’t miss the opportunity to meet with Monica Gostissa, our CSO, who will be presenting at the Treg-Directed Therapies Summit. Monica Gostissa will discuss our most recent developments in Targeted Approaches to Balance Treg Function in Inflammation & Cancer. #autoimmunity #autoimmunedisease #IL2 #cytokinetherapy
Egle Therapeutics
Recherche en biotechnologie
Modulating T-regulatory cells to balance immunity
À propos
Egle Therapeutics has been founded with a vision to become a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Tregs’ starving while specifically targeting the most immunosuppressive ones.
- Site web
-
http://www.egle-tx.com
Lien externe pour Egle Therapeutics
- Secteur
- Recherche en biotechnologie
- Taille de l’entreprise
- 11-50 employés
- Siège social
- Paris
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2020
Lieux
-
Principal
Obtenir l’itinéraire
Paris, FR
Employés chez Egle Therapeutics
Nouvelles
-
We are thrilled to announce the appointment of John Celebi, MBA, as Independent Board Member. John brings over 25 years of experience building innovative entrepreneurial biotechnology companies, his expertise in business development in the field of oncology will be instrumental for us to successfully execute on our strategic priorities.
-
-
We are thrilled to announce the appointment of Pejvack Motlagh, MD, MSc, as Chief Medical Officer. Pejvack will be responsible for advancing Egle’s pipeline towards the clinic and notably our most advanced candidate EGL-001 in oncology and EGL-003 our lead candidate in auto-immune diseases.
-
-
Egle Therapeutics is thrilled to announce its upcoming participation to Bio€quity Europe 2024 from May 12 to May 14. Do not miss the opportunity to meet with our executive team. We’ll be delighted to share on our novel Treg-specific targets and on the current development of our Treg-focused drug candidates in oncology and autoimmune diseases. Egle Therapeutics #BioequityEurope #TREG #ImmunoOncology #Autoimmunity
-